Bright Minds Biosciences, Inc. (DRUG.CX)
118.00
+2.44
(+2.11%)
CAD |
CNSX |
Dec 24, 16:00
Bright Minds Biosciences Market Cap: 918.89M for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| 4Front Ventures Corp. | 4.576M |
| Green Thumb Industries, Inc. | 2.584B |
| Lowell Farms, Inc. | 0.2722M |
| Vireo Growth, Inc. | 807.33M |
| Wesana Health Holdings, Inc. | 0.2008M |
Market Cap Related Metrics
| PEG Ratio | -0.4566 |
| Price to Book Value | 11.20 |
| Price | 118.00 |
| Earnings Yield | -1.46% |
| PEGY Ratio | -0.4566 |